Document Security Systems

DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and/or acquire assets and investments in the securities trading and/or funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.

Document Security Systems, Inc. (NYSE: DSS) announced the promotion of Todd D. Macko to Chief Financial Officer effective August 16, 2021.

Document Security Systems Names Todd Macko Finance Chief

Document Security Systems Inc's (NYSE: DSS) subsidiary, DSS Biomedical International, Inc., has completed a $1 million equity investment in Vivacitas Oncology, Inc. Vivacitas Oncology focuses on developing new treatment options to treat cancers resistant to currently available therapies.

Document Security Systems Invests $1M In Vivacitas Oncology

ROCHESTER, NY / ACCESSWIRE / August 2, 2021 / Document Security Systems, Inc. ("DSS" or the "Company") (NYSE American:DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, announced today that its subsidiary, DSS Biomedical International, Inc. ("DSS Biomedical"), completed a $1 million equity investment in Vivacitas Oncology, Inc. ("Vivacitas"), a clinical-stage company focused on difficult-to-treat cancers. "We continue to demonstrate our commitment to addressing unmet needs in human healthcare and wellness through key strategic investments," stated Frank D.

DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology

Alset EHome International

BETHESDA, MD / ACCESSWIRE / July 26, 2021 / Alset EHome International Inc. (NASDAQ:AEI) ("AEI" the "Group" or "Company"), a diversified holding company principally engaged through its subsidiaries in the development of EHome communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce that American Medical REIT ("AMRE", or the "REIT") successfully completed the acquisition of Ivy Brook Medical Center ("Ivy Brook"), a 40,000 square foot first-class medical facility located in Shelton, Connecticut. Considered Fairfield County's most prestigious medical facility, Ivy Brook provides a vast array of medical practices and related services in a patient-friendly and inviting outpatient campus.

American Medical REIT Forges Ahead with Maiden Acquisition of Ivy Brook Medical Center in Connecticut

Galecto

Savara

There are some investors who invest in U.S.-listed stocks that are trading below their liquidation values because they believe they can make huge margins of return out of these stocks after the market has reappraised the share prices to near or above the liquidation value.

3 Net Current Asset Value Stock Picks

Acasti Pharma

GEE Group

Meten Holding Group Ltd.

New Gold

Are these top penny stocks worth watching in July 2021? The post 5 Hot Penny Stocks You Need to Know About in 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Hot Penny Stocks You Need to Know About in 2021

ROCHESTER, N.Y., July 06, 2021 (GLOBE NEWSWIRE) -- Impact Biomedical Inc., a wholly owned subsidiary of Document Security Systems Inc. (NYSE American: DSS), today announced updates to several of its key research projects, including key collaborations, breakthroughs in treatment protocols and potential global licensing opportunities as a way to begin planning the next phase of its research agenda and position itself as a global leader in the future of biotech.

DSS's Impact Biomedical Provides Updates on Key Research Projects and Global Licensing Opportunities

Dogness

Kintara Therapeutics

LiveXLive Media

National CineMedia

TDH Hlds

Pixelworks

If you really want to take a walk on the wild side, there are several stocks to buy under $5. But be prepared for unpredictability.

7 Stocks to Buy Under $5 for Big Gains

Former co-head of Societe Generale equity derivatives in Asia and former Citadel portfolio manager team up with DSS and bring track record of 20% per annum returns Former co-head of Societe Generale equity derivatives in Asia and former Citadel portfolio manager team up with DSS and bring track record of 20% per annum returns

DSS Forms Liquid Value Asset Management to Capitalize on Algorithmic Trading Opportunities with Attractive Risk Adjusted Returns

Ivy Brook is Fairfield County, Connecticut's most prestigious medical facility Ivy Brook is Fairfield County, Connecticut's most prestigious medical facility

DSS Adds Ivy Brook Medical Center to its American Medical REIT Portfolio

BOSTON--(BUSINESS WIRE)--Proof Authentication Corporation today announced that Dan McKinnon has been appointed as CEO in connection with its recently closed Series A financing. Prior to joining Proof, Dan was the Head of Global Brand Protection at New Balance, one of the world's largest sports footwear and apparel manufacturers. NYC-based VCFA Group led the round to fund the secondary buyout of DSS Digital, Inc., a leader in anti-counterfeit authentication technology and brand protection soluti

Proof Authentication Announces Close of Series A Funding and Appointment of Brand Protection Veteran Dan McKinnon as New CEO

NEW YORK, NY / ACCESSWIRE / June 17, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $50 Million Public Offering of Common Stock Including Exercise of the Over-Allotment for Document Security Systems, Inc. (NYSE American:DSS). About Document Security Systems, Inc. DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets.

Aegis Capital Corp. acted as Sole Bookrunner on a $50 Million Public Offering of Common Stock Including Exercise of the Over-Allotment for Document Security Systems, Inc. (NYSE American: DSS)

ROCHESTER, N.Y., June 17, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced the closing of an underwritten public offering as well as the simultaneous exercise of the underwriter's over-allotment option for total gross proceeds to the Company of $50.025 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Document Security Systems, Inc. Closes $50.025 Million Public Offering of Common Stock Including Exercise of the Over-Allotment

ROCHESTER, N.Y., June 16, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) received notice of issuance (US 10,966,424) from the U.S. Patent and Trademark Office (“USPTO”) for 3FDB, a Functional Fragrance Formulation (3F) technology that increases the effectiveness of current mosquito repellants through a delightfully fragrant compound derived from botanical oils.

DSS's Impact BioMedical Receives US Patent for its Functional Fragrance Formulation Mosquito Repellant Booster

ROCHESTER, N.Y., June 14, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $43.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Document Security Systems, Inc. Prices $43.5 Million Public Offering of Common Stock

DSS has option to buy additional 50.1% of Sentinel DSS has option to buy additional 50.1% of Sentinel

DSS Expands Footprint of DSS Securities through Acquisition of 24.9% of Broker-Dealer Sentinel Brokers Company

Document Security Systems stock has been trading down since the start of the year. The stock has recently faced even more pressure due to the sale of DSS Digital.

Document Security Systems: Strong Cash Position, Remarkably Cheap Stock

A study done by the University of Florida using the SARS-CoV-2 virus showed a significant decrease in infectivity of the virus immediately after exposure to Puradigm's technology

DSS Launches DSS PureAir, Inc. and Makes Investment into Innovative Proactive Air and Surface Purification Solutions Technology from Puradigm LLC

Company focused on growing shareholder value through higher return opportunities Company focused on growing shareholder value through higher return opportunities

DSS Sells its DSS Digital Division to Proof Authentication Corporation

Premier expects to receive up to $700K in state tax credits to support the move Premier expects to receive up to $700K in state tax credits to support the move

DSS's Premier Packaging Subsidiary Expands Operations with New 105,000 Sq. Ft. Facility to Meet Growing Customer Demand

ROCHESTER, N.Y., April 08, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced DSS Biomedical International, Inc. (“DSS Biomedical”), a subsidiary of Impact BioMedical, Inc., a wholly owned subsidiary of the Company, completed an equity investment in Vivacitas Oncology, Inc. (“Vivacitas”), a clinical-stage company focused on difficult to treat cancers.

DSS Expands its Healthcare Segment through Investment in Vivacitas Oncology

ROCHESTER, N.Y., April 07, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses in consumer packaging, brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the launch of Alset Solar, Inc. (“Alset Solar”).

DSS Launches Alset Solar to Develop Utility-Scale Solar Farms at Superfund Sites and Other Underutilized Properties

ROCHESTER, N.Y., April 06, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) received notice of allowance (US 16/544,308) from the U.S. Patent and Trademark Office (“USPTO”) for a method of limiting the occurrence of, reducing the risk or severity of, or treating Ebola and Rhinovirus using its proprietary Equivir compound.   This allowance is in addition to Equivir's previously issued U.S. patent in influenza.

UPDATE - DSS's Impact BioMedical Receives Notice of Allowance from USPTO for Equivir Patent

DSS's Impact BioMedical Receives Notice of Allowance from USPTO for Equivir Patent

Generated positive income of $3.1M vs. a loss of $2.6M in 2019 Revenue up 12% to $17.4M in 2020 Stockholders' Equity up 522% to $76.5M

News for Document Security Systems Stock (DSS)